Drug Discovery


Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/australian-government-offers-100m-fund-for-brain-cancer-research/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/nih-found-new-target-proteins-for-anti-malaria-drugs/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26
share

A team of scientists has found a new target for triple-negative breast cancer. Triple-negative breast cancer, which is...

share

Sanofi Genzyme and Principia Biopharma have entered into a license agreement to advance the clinical development of PRN2246, an...

share

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

share

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics announced a partnership to discover and develop novel therapeutics for liver...

share

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic...

share

Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to...

share

The Government of Australia announced new funding of $100m to advance brain cancer research as part of efforts...

share

A new study funded by the National Institutes of Health (NIH) in the US identified two proteins required...